Studies in recent years have indicated that aberrant PER1 expression was highly linked to the carcinogenesis and development of malignant tumors, such as prostate cancer, colon cancer, leukocythemia and breast cancer et al [12]–[17]. This evidence concerns the gene PER1 and prostate carcinoma.